PharmacyCodes



Tekodin en es it fr

Categorie

Tekodin Les marques, Tekodin Analogs

Tekodin Les marques melange

  • Combunox
  • ENDOCET
  • PERCOCET
  • ENDODAN
  • Percodan-Demi (Acetylsalicylic Acid + Oxycodone Hydrochloride)
  • Pms-Oxycodone - Acetaminophen (Acetaminophen + Oxycodone (Oxycodone Hydrochloride))
  • Rivacocet (Acetaminophen + Oxycodone (Oxycodone Hydrochloride))
  • Roxicet Tab (Acetaminophen + Oxycodone Hydrochloride)

    • Tekodin Formule chimique

    C18H21NO4

    Tekodin RX lien

    http://www.rxlist.com/cgi/generic2/oxyco.htm

    Tekodin FDA fiche

    Tekodin FDA

    Tekodin msds (fiche de securite des materiaux)

    Tekodin MSDS

    Tekodin Synthese de reference

    Petit, Lutz, "Chimie de l'alcaloïdes de l'opium", Suppl.No.103 (1932)

    Tekodin Poids moleculaire

    315.364 g/mol

    Tekodin Point de fusion

    218-220 oC

    Tekodin H2O Solubilite

    100 mg / ml

    Tekodin Etat

    Solid

    Tekodin LogP

    0.993

    Tekodin Formes pharmaceutiques

    Tablet; Suppositoire

    Tekodin Indication

    Pour le traitement de la diarrhée, œdème pulmonaire; Pour le soulagement de la douleur modérée à modérément sévère

    Tekodin Pharmacologie

    L'oxycodone est un agoniste des opiacés semi-synthétique dérivé de l'opioïde alcaloïde, la thébaïne, est similaire à d'autres dérivés du phénanthrène comme l'hydrocodone et la morphine. L'oxycodone est disponible en combinaison avec l'aspirine ou l'acétaminophène pour contrôler la douleur et des jambes sans repos et les syndromes de Tourette.

    Tekodin Absorption

    bien absorbé des comprimés OxyContin ® avec une biodisponibilité orale de 60% à 87%

    Tekodin Toxicite

    dépression respiratoire, une somnolence progressant vers la stupeur ou le coma, la flaccidité des muscles squelettiques, peau froide et moite, contraction des pupilles, la bradycardie, l'hypotension et la mort.

    Tekodin Information pour les patients

    WARNINGS

    Drug Dependence: Oxycodone can produce drug dependence of the morphine type, and therefore, has the potential for being abused. Psychic dependence, physical dependence and tolerance may develop upon repeated administration of this drug, and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic-containing medications. Like other narcotic-containing medications, this drug is subject to the Federal Controlled Substances Act.

    Usage in Ambulatory Patients: Oxycodone may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. The patient using this drug should be cautioned accordingly.

    Interaction with Other Central Nervous System Depressants: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, other tranquilizers, sedative-hypnotics or other CNS depressants (including alcohol) concomitantly with oxycodone hydrochloride may exhibit an additive CNS depression. When such combined therapy is contemplated, the dose of one or both agents should be reduced.

    Usage in Pregnancy: Safe use in pregnancy has not been established relative to possible adverse effects on fetal development. Therefore, this drug should not be used in pregnant women unless, in the judgment of the physician, the potential benefits outweigh the possible hazards.

    Usage in Children: This drug should not be administered to children.

    PRECAUTIONS

    Head Injury and Increased Intracranial Pressure: The respiratory depressant effects of narcotics and their capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury, other intracranial lesions or a pre-existing increase in intracranial pressure. Furthermore, narcotics produce adverse reactions which may obscure the clinical course of patients with head injuries.

    Acute Abdominal Conditions: The administration of this drug or other narcotics may obscure the diagnosis or clinical course in patients with acute abdominal conditions.

    Special Risk Patients: This drug should be given with caution to certain patients such as the elderly, or debilitated, and those with severe impairment of hepatic or renal function, hypothyroidism, Addison's disease and prostatic hypertrophy or urethral stricture.

    Tekodin Organismes affectes

    Les humains et autres mammifères